MoneyWorks4Me

Integris Medtech Ltd

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Trading | | Integris Medtech Share Price

BSE Share Price
Not Listed

Integris Medtech Ltd

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Trading | | Integris Medtech Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹0 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
-
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
6.42%
Return on Capital Employed (ROCE)
7.78%
Return on Assets (ROA)
2.16%
Operating Profit Margin
14.9%
Net Profit Margin
3.72%
Gross Profit Margin
12.5%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
-34.25%
Operating Profit Growth (1 Year)
-
51.16%
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
%
Pledged shares (%) of Promoter's holding (%)
%
Reserves
-
Equity
-
Face Value
-
All Time Low / High
- / -

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Mar'23Mar'24Mar'25TTM
ROCE % 3.4%5.9%4.1%-

Growth Parameters

Sales 62.758.338.30
Sales YoY Gr.--7%-34.3%-
Adj EPS 4.26.56.40
YoY Gr.-56.5%-2.9%-
BVPS (₹) 126.6132.7202.50
Adj Net
Profit
2132.837.5NAN
Cash Flow from Ops. 6.7-13.8-66.1-
Debt/CF from Ops. 2.3-6.2-0-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NANANA-34.3%
Adj EPS NANANA-2.9%
BVPSNANANA52.6%
Share Price - - - -

Key Financial Parameters

Mar'23Mar'24Mar'25TTM
Return on
Equity %
3.34.83.90
Op. Profit
Mgn %
1.51.7-17.3NAN
Net Profit
Mgn %
33.456.297.7NAN
Debt to
Equity
00.10-
Working Cap
Days
05591,2550
Cash Conv.
Cycle
0-126940

Valuation of Integris Medtech - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Financials

PARTICULARSMar'23Mar'24Mar'25
Sales1,348.101,553.381,902.47
Operating Expenses + 1,192.901,365.681,618.75
Manufacturing Costs10.939.1614.12
Material Costs775.51880.891,066.32
Employee Cost 247.30278.80349.16
Other Costs 159.16196.83189.16
Operating Profit 155.21187.70283.72
Operating Profit Margin (%) 11.5%12.1%14.9%
Other Income + 21.5528.8857.12
Exceptional Items -83.30-26.34-32.66
Interest 38.7867.2873.48
Depreciation 84.71103.98134.55
Profit Before Tax -14.5425.62114.55
Tax 2630.5043.87
Profit After Tax -40.54-4.8870.68
PAT Margin (%) -3.0%-0.3%3.7%
Adjusted EPS (₹)-19.2-2.45.6
Dividend Payout Ratio (%)0%0%0%
PARTICULARSMar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 1,074.061,136.551,129.37
Share Capital 2.7166.173
Reserves 1,071.361,070.381,126.37
Debt +520.09627.371,514.86
Long Term Debt282.27402.42491.45
Short Term Debt237.82224.951,023.41
Minority Interest385.17433.72167.59
Trade Payables168.28187.49202.35
Others Liabilities 377.85561.54581.68
Total Liabilities 2,525.462,946.673,595.85

Fixed Assets

Net Fixed Assets +1,083.701,350.021,358.34
Gross Block1,383.981,739.371,877.89
Accumulated Depreciation300.28389.35519.55
CWIP 3.6714.8522.74
Investments 402.39357.85706.60
Inventories248.99297.04316.47
Trade Receivables394.86489.79533.36
Cash Equivalents 239.28268.08487.63
Others Assets 152.58169.04170.71
Total Assets 2,525.462,946.673,595.85
PARTICULARSMar'23Mar'24Mar'25
Cash Flow From Operating Activity + 19.4497.26155.54
PBT -14.5425.62114.55
Adjustment 182.52176.70217.22
Changes in Working Capital -104.8-54.52-120.91
Tax Paid -43.73-50.55-55.32
Cash Flow From Investing Activity + -129.95-355.29-608.59
Capex -49.41-52.82-80.91
Net Investments -87.25-235.57-506.95
Others 6.71-66.90-20.74
Cash Flow From Financing Activity + 147.23258.59445.11
Net Proceeds from Shares 00354.01
Net Proceeds from Borrowing 133.72186.082.59
Interest Paid -29.68-49.23-59.20
Dividend Paid 000
Others 43.18121.73147.71
Net Cash Flow 36.720.55-7.94
PARTICULARSMar'23Mar'24Mar'25
Ratios
ROE (%)-3.78-0.466.42
ROCE (%)1.485.187.78
Asset Turnover Ratio0.610.670.65
PAT to CFO Conversion(x)N/AN/A2.2
Working Capital Days
Receivable Days93.1088.4087.30
Inventory Days58.7054.6052.40
Payable Days79.2073.7066.70

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Integris Medtech Ltd FAQs

The current trading price of Integris Medtech on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Integris Medtech stood at ₹0.00 Cr

The latest P/E ratio of Integris Medtech as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Integris Medtech as of 31-Dec-1969 is 0.00.

The 52-week high of Integris Medtech is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Integris Medtech is ₹0.00 ( Cr.) .

Data is not available for this company.

No data found

No data found

About Integris Medtech Ltd

No data to display
You have 46 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now